Mirati Therapeutics

Graphic image of a man climbing up a latter in front of a beige background with clouds and a blue splotch of sky
Biotech

Charles Baum takes over Terremoto as CEO

Charles Baum, M.D., Ph.D., who oversaw Mirati's $5.8 billion sale to BMS last year, is taking the helm of Terremoto Biosciences.
Darren Incorvaia Jul 25, 2024 11:55am
Photo of a parachutes opened with a dark blue sky in the background

John Cox gets new biotech CEO gig at Dyne—Chutes & Ladders

Mar 29, 2024 9:30am
Palm tree branches bending as storm clouds approach

Frontier CEO weathers one of his hardest fundraises to add $80M

Feb 22, 2024 4:01pm
Merck MSD ESMO 2023

Merck's early KRAS data suggest combination-friendly safety

Oct 23, 2023 9:45am
A histology stain of pancreatic ductal adenocarcinoma

KRAS inhibitor, immunotherapy halts pancreatic cancer in mice

Aug 29, 2023 9:56am
Parachute

Leaps by Bayer chief jumps to Bayer, too—Chutes & Ladders

Aug 25, 2023 9:30am